Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will go to $150,000 — or more. But there’s one coin he thinks could go even higher.

Christophe Couturier net worth and biography

Christophe Couturier Biography and Net Worth

EVP of Avantor

Christophe Couturier is our Executive Vice President, AMEA. He has extensive strategic leadership experience in the life sciences industry. Mr. Couturier leads sales, marketing and customer service for our business in AMEA, as well as the Avantor Business System and its associated LEAN processes globally. Prior to this role, Mr. Couturier was the Executive Vice President, Services. Before joining Avantor, Mr. Couturier led business areas of services, merger integration, general management, finance and consulting at life sciences companies, including more than a decade with MilliporeSigma. He earned a Master of Science in management from ESSEC Business School in France.

What is Christophe Couturier's net worth?: The estimated net worth of Christophe Couturier is at least $2.04 million as of April 11th, 2023. Mr. Couturier owns 98,650 shares of Avantor stock worth more than $2,040,082 as of November 22nd. This net worth approximation does not reflect any other assets that Mr. Couturier may own. Learn More about Christophe Couturier's net worth.
How do I contact Christophe Couturier?: The corporate mailing address for Mr. Couturier and other Avantor executives is BUILDING ONE SUITE 200 100 MATSONFORD ROAD, RADNOR PA, 19087. Avantor can also be reached via phone at (610) 386-1700 and via email at [email protected]. Learn More on Christophe Couturier's contact information.
Has Christophe Couturier been buying or selling shares of Avantor?: Christophe Couturier has not been actively trading shares of Avantor over the course of the past ninety days. Most recently, Christophe Couturier sold 1,498 shares of the business's stock in a transaction on Tuesday, April 11th. The shares were sold at an average price of $21.18, for a transaction totalling $31,727.64. Following the completion of the sale, the executive vice president now directly owns 98,650 shares of the company's stock, valued at $2,089,407. Learn More on Christophe Couturier's trading history.
Who are Avantor's active insiders?: Avantor's insider roster includes James Bramwell (EVP), Gerard Brophy (EVP), Christophe Couturier (EVP), Steven Eck (CAO), Rajiv Gupta (Director), Justin Miller (EVP), Jo Natauri (Director), Devashish Ohri (EVP), Christi Shaw (Director), Michael Stubblefield (CEO), Thomas Szlosek (CFO), Frederic Vanderhaegen (EVP), and Michael Wondrasch (EVP). Learn More on Avantor's active insiders.
Are insiders buying or selling shares of Avantor?: In the last twelve months, insiders at the sold shares 2 times. They sold a total of 9,728 shares worth more than $240,247.97. The most recent insider tranaction occured on September, 5th when CAO Steven W Eck sold 3,525 shares worth more than $88,336.50. Insiders at Avantor own 1.5% of the company. Learn More about insider trades at Avantor.
Information on this page was last updated on 9/5/2024.

Christophe Couturier Insider Trading History at Avantor

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
4/11/2023	Sell	1,498	$21.18	$31,727.64	98,650
2/23/2023	Sell	3,078	$24.24	$74,610.72	94,370
12/27/2021	Sell	10,184	$41.63	$423,959.92
12/21/2021	Sell	38,309	$41.00	$1,570,669.00
12/8/2021	Sell	5,828	$40.00	$233,120.00
6/28/2021	Sell	28,096	$35.73	$1,003,870.08	110,077

Christophe Couturier Buying and Selling Activity at Avantor

Avantor Company Overview

Avantor, Inc. engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips. It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, and critical environment supplies. In addition, the company offers services and specialty procurements comprising onsite lab and production, clinical, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services. Further, it provides scientific research support services, such as DNA extraction, bioreactor servicing, clinical and biorepository, and compound management services. The company was founded in 1904 and is headquartered in Radnor, Pennsylvania.

Today's Range

Now: $20.68

$20.25

$20.71

50 Day Range

MA: $24.01

$19.72

$27.70

2 Week Range

Now: $20.68

$19.59

$28.00

Volume

2,146,114 shs

Average Volume

6,478,400 shs

Market Capitalization

$14.08 billion

P/E Ratio

44.96

Dividend Yield

N/A

Beta

1.35

Buffett Dumps $982 Million in BofA Stock—What Does He Know?

From Genesis Gold Group | Ad

Buffett's been eerily quiet about his reasons, but his actions speak volumes. When someone with his track record starts pulling out of the market, it's time to pay attention.

Get your FREE, no-obligation Wealth Protection Guide now